BioUtah News
-
Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology
Asset acquisition would expand Merit’s Endoscopy portfolio with an innovative device to treat patients suffering from Barretts esophagus…
-
Canary Speech Launches Canary Ambient™ Continuous Monitoring to Address Workplace Violence in Healthcare
AI-powered voice analysis expands to detect verbal aggression and prevent nurse burnout through real-time vocal biomarker technology, enhancing…
-
Owlet™ Secures CDSCO Approval for Dream Sock® and Plans 2026 Expansion into India
Owlet expands its global footprint, entering one of the world’s most promising digital health markets, with CDSCO-approved technology.
-
NUSANO AND ARICEUM THERAPEUTICS ANNOUNCE MULTI-ISOTOPE SUPPLY AGREEMENT
AGREEMENT INCLUDES ACTINIUM-225 (AC-225) AND LUTETIUM-177 (LU-177) TO SUPPORT ARICEUM’S THERAPEUTIC PROGRAMS
-
CancerVax Precision Therapy Successfully Avoids Healthy Liver Cells
In-vitro studies confirm that the Company’s novel Smart mRNA could drastically reduce off-target liver toxicity, a major issue…
-
Halia Therapeutics Expands to Abu Dhabi
Halia Therapeutics Expands to Abu Dhabi
-
Leash Bio Announces Multi-Target Agreement with Monte Rosa Therapeutics
Leash Bio Announces Multi-Target Agreement with Monte Rosa Therapeutics
-
Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology
SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care.
-
PhotoPharmics to Feature Photo Neurostimulation at the 2025 Movement Disorders Society International Congress
Attendees invited to Booth #732 for pivotal trial updates and to discuss unmet needs in Parkinson’s care.
-
Halia Therapeutics Named as 2025 Top 10 Longevity Breakthrough Award Winner
Halia Therapeutics Named as 2025 Top 10 Longevity Breakthrough Award Winner
-
Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™
BioSeeker mapped more than 10,000 isolates and identified targetable regions that provide 100% strain coverage across the viral…
-
Biolexis Therapeutics Initiates First-in-Human Clinical Trials for Novel, Oral Muscle-Sparing, Weight Loss and Type 2 Diabetes Therapies
Biolexis Therapeutics Initiates First-in-Human Clinical Trials for Novel, Oral Muscle-Sparing, Weight Loss and Type 2 Diabetes Therapies
-
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to…
-
2025 MedTech Conference Sponsored by AdvaMed
This week AdvaMed held its annual Medtech Conference, designed for those in the medical technology industry.
-
Nucleus Grow Hosts State of Innovation Conference
The State of Innovation Conference, hosted by The Nucleus Institute, brought together entrepreneurs, investors, policymakers, and researchers to…
-
Nelson Labs’ 40th Anniversary Celebration Recap
Nelson Labs on October 1 celebrated a milestone 40th anniversary. Since its humble beginnings in 1985 in University…
-
ARUP’s Advanced Practice Laboratory: A National Model for Bridging Education and Industry
September 30, Salt Lake City—In a groundbreaking collaboration between ARUP Laboratories and the University of Utah, the new…
-
Glafabra Therapeutics, Uncommon Cures Collaborate to Advance Fabry Disease Therapy
Glafabra Therapeutics, Uncommon Cures Collaborate to Advance Fabry Disease Therapy
-
Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network, Rapid Response Partnership Vehicle
Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV)
-
Innovative Wearable for Pelvic Floor Health by Freyya Completes Clinical Study
Innovative Wearable for Pelvic Floor Health by Freyya Completes Clinical Study
-
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
-
Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East
The Memorandum of Understanding includes the formation of a Joint Venture in the Kingdom of Saudi Arabia for…
-
Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease
Definitive agreement to accelerate adoption of Renalytix’s FDA-approved, Medicare reimbursed kidneyintelX.dkd test to slow kidney disease progression and…
-
KUDA THERAPEUTICS AWARDED $5.6M U.S. DoD GRANT TO BRING LEAD ONCOLOGY CANDIDATE INTO CLINIC
KUDA THERAPEUTICS AWARDED $5.6M U.S. DoD GRANT TO BRING LEAD ONCOLOGY CANDIDATE INTO CLINIC
-
ARUP Achieves Reaccreditation Under College of American Pathologists ISO 15189 Program
ARUP Achieves Reaccreditation Under College of American Pathologists ISO 15189 Program
-
Altesa BioSciences and bioMérieux Announce Collaboration for Altesa’s Upcoming Phase 2B COPD Clinical Trial
Study will begin enrollment in Q1 2026 in the US and UK and leverage the BIOFIRE® SPOTFIRE® point-of-care…
-
Owlet Makes Premium Monitoring Possible for Every Family With New Dream Sight™ Video Monitor
Owlet’s new release creates the ultimate baby monitoring system for video, sleep, and medical-grade health tracking.
-
BioUtah Member Appreciation BBQ 2025 Recap
BioUtah Member Appreciation BBQ 2025 Recap
-
Kimbell & Associates: Trump Administration Issues MAHA Strategy Report of Recommendations to President Trump
Kimbell & Associates: Trump Administration Issues MAHA Strategy Report of Recommendations to President Trump
-
Arcutis Submits Supplemental New Drug Application for ZORYVE® (roflumilast) Cream 0.3% to Expand Indication for Treatment of Plaque Psoriasis in Children Ages 2 to 5
If approved, ZORYVE cream would be the first and only topical PDE4 inhibitor indicated for plaque psoriasis in…
-
Salt Lake City Angels Invests in Freyya
Salt Lake City Angels Invests in Freyya
-
Owlet Extends Global Reach with Launch of Medically-Certified Dream Sock™ to South Africa
The wearable baby monitor trusted by millions globally expands reach to three continents, including North America, Europe, and…
-
Legendary Scientist and Biotech Veteran Joins CancerVax as Strategic Advisor
Dr. Gordon Ringold to advise on various strategies related to the development of the Company’s novel cancer treatment…
-
BD Expands Peripheral Artery Disease Awareness Efforts with ‘Love Your Limbs’ Community Screening Initiative
BD Expands Peripheral Artery Disease Awareness Efforts with ‘Love Your Limbs’ Community Screening Initiative
-
PhotoPharmics Forms Commercial Advisory Board to Guide Market Launch of Breakthrough Parkinson’s Therapy
Renowned leaders in neurology, movement disorders, and commercialization join to shape Celeste® market strategy
-
Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss
Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of…
-
Halia Therapeutics Published in Journey of Drug Targeting
Halia Therapeutics Published in Journey of Drug Targeting
-
CancerVax Achieves Major Milestones and Files Foundational Patent Application
The Company filed a substantial non-provisional PCT patent application seeking worldwide protection for its novel cancer treatment platform
-
Epic Ventures Gains $200M Fresh Capital
Epic Ventures Gains $200M Fresh Capital
-
Canyon Labs Open House
Canyon Labs Opens Expanded Facility
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
